Support for hemostatic technology research and the manufacturing of hemostatic products.
2026 · 3rd Quarter (July 1 - Sep 30)
CRESILON, INC.
Filed by THE CONAFAY GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- THE CONAFAY GROUP, LLC
- Client
- CRESILON, INC.
- Filing UUID
- a896d058-9a49-4a92-ab5b-cb56eeadd84f
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Support for hemostatic technology research and the manufacturing of hemostatic products.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.